# South Korea Infection Control Human and Animal Health Market > South Korea Infection Control for the Human Animal Health Market Research Report By Product (Disinfection Products, Personal Protective Equipment (PPE), Sterilization Equipment), By Infection Type (Viral, Bacterial, Parasitic, Fungal Infections) and By End User (Human Healthcare Facilities, Animal Healthcare Facilities) -Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.43% - **2023:** $ 191.2 Million - **2024:** $ 1,250 Million - **2035:** $ 2,750 Million - **Key Players:** Agrovet Market, Bayer Animal Health, Vetoquinol, Phileo Lesaffre Animal Care, Merck Animal Health, Huvepharma, Boehringer Ingelheim, Virbac, Elanco Animal Health, Vetbiobank, Cegelec, NEOGEN Corporation, Zoetis, Petmed Express, Cypress Drug Company **Report ID:** MRFR/HC/51628-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-infection-control-human-and-animal-health-market-53389 --- ## Market Summary ## **South Korea Infection Control for the Human Animal Health Market Overview** As per MRFR analysis, the South Korea Infection Control for the Human Animal Health Market Size was estimated at 191.2 (USD Million) in 2023. The South Korea Infection Control for the Human Animal Health Market Industry is expected to grow from 206.8(USD Million) in 2024 to 500 (USD Million) by 2035. The South Korea Infection Control for the Human Animal Health Market CAGR (growth rate) is expected to be around 8.357% during the forecast period (2025 - 2035). **Key South Korea Infection Control for the Human Animal Health Market Trends Highlighted** In South Korea, the infection control for the human-animal health market is experiencing significant growth, driven by rising awareness of zoonotic diseases. The increase in urbanization and proximity between humans and animals is fostering a demand for effective infection control measures. Additionally, the COVID-19 pandemic has heightened the focus on both animal and human health, leading to an uptick in research and development of vaccines and therapeutics. The South Korean government's commitment to enhancing agricultural biosafety and promoting veterinary public health is also a key market driver. This is reflected in initiatives aimed at improving surveillance and control measures for infectious diseases affecting livestock and companion animals.Opportunities within this market are abundant, particularly in the realm of innovative technologies and solutions, such as rapid diagnostic tests and advanced vaccines. With South Korea being a leader in technological advancements, there is ample scope for the integration of smart technologies in infection control protocols. Furthermore, with the Korean government's proactive stance in supporting animal health industries, private enterprises could collaborate with the public sector to explore potential synergies for better health outcomes. Recent trends show a growing investment in education and training for veterinary professionals to better equip them in handling infectious diseases. This trend underscores the importance of advanced knowledge in practicing effective infection control. Additionally, the increasing consumer demand for safe and healthy food products is placing pressure on the agricultural sector to uphold strict infection control standards. Overall, these elements are shaping a robust framework for the infection control market in South Korea, making it a critical area of focus for stakeholders in human and animal health. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **South Korea Infection Control for the Human Animal Health Market Drivers** **Increasing Awareness of Zoonotic Diseases** In recent years, zoonotic diseases—diseases that may spread from animals to people—have been much more widely recognized in South Korea. Zoonose instances have increased significantly over the last ten years, according to the Korean Centers for Disease Control and Prevention (KCDC). This is especially true during the COVID-19 pandemic, which brought attention to the connection between human and animal health. Because of the increased need for efficient infection control solutions and increased public awareness, the South Korea infection control for human and animal health market is expected to rise. Investment in the field has increased as a result of the KCDC's aggressive promotion of immunization programs and public health initiatives meant to avoid these illnesses. As more households become aware of the hazards associated with zoonotic illnesses, the market is anticipated to grow as a result of an increase in public health activities and a rise in the number of families adopting pets. **Government Initiatives and Investments in Animal Health** The South Korean government has been actively pursuing initiatives to enhance animal health and control infections. Recent policies have included increased funding for the Research and Development (R&D) of veterinary vaccines and treatments. The Ministry of Agriculture, Food and Rural Affairs has allocated substantial budget increases towards research efforts aimed at preventing animal diseases that can affect human health. This state-backed investment not only encourages innovation in the South Korea Infection Control for the Human Animal Health Market Industry but also supports local companies in developing more effective infection control products.A commitment of 20 percent annual growth in veterinary medicines indicates the pressing need for improved infection control in animal healthcare, which is projected to facilitate significant advancements and market growth. **Rising Pet Ownership Trends** In recent years, South Korea has seen a dramatic rise in pet ownership, which in turn is expected to drive the demand for comprehensive infection control measures in the health sector. According to the Korean Statistical Information Service, the pet ownership rate in South Korea has surged to nearly 60 percent of households, amounting to over 7 million pet dogs and cats. As pet owners increasingly seek to ensure the health and safety of their animals, there is a corresponding need for high-quality veterinary services and products aimed at infection prevention.This trend directly contributes to the growth of the South Korea Infection Control for the Human Animal Health Market Industry as more consumers and professionals seek effective solutions for health maintenance and disease prevention in their pets. **Technological Advancements in Disease Detection** Recent advancements in technology have significantly improved the methods available for disease detection and management in both animal and human health. The growing adoption of diagnostic technologies such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) in veterinary practices in South Korea has enhanced the accuracy and speed of identifying infectious diseases, especially those affecting zoonotic pathways. The Korean Veterinary Medical Association has emphasized the importance of integrating these technologies into everyday practices to improve overall animal health monitoring.This shift towards proactive disease management is set to bolster the South Korea Infection Control for the Human Animal Health Market Industry.By increasing the capacity for rapid response to emerging health threats, veterinary clinics are more likely to implement rigorous infection control protocols, thus playing a vital role in the market's expansion. **South Korea Infection Control for the Human Animal Health Market Segment Insights** **Infection Control for the Human Animal Health Market Product Insights** The Product segment of the South Korea Infection Control for the Human Animal Health Market plays a critical role in ensuring health safety across populations and industries. This market encompasses various solutions designed to prevent the spread of infections, highlighting the importance of hygiene in both human and animal health contexts. Disinfection Products are essential in mitigating pathogens, with a significant portion of the industry focusing on developing and distributing effective antimicrobial agents for various surfaces and environments, particularly given the high population density and urbanization observed in South Korea. Personal Protective Equipment (PPE) is another vital aspect of this segment, providing necessary safeguards for healthcare workers, veterinarians, and public health officials, especially during outbreaks or situations requiring stringent infection control measures. Furthermore, Sterilization Equipment plays a significant role in clinical settings, ensuring that surgical instruments and other medical devices are free from contamination, thereby enhancing patient safety. The demand for these products is driven by increasing awareness regarding healthcare-associated infections and animal disease outbreaks, along with strengthening regulations and standards governing infection control protocols. South Korea's proactive approach to public health, coupled with advancements in biotechnology, continues to influence the development and adoption of innovative products within this sector. Consequently, the South Korea Infection Control for the Human Animal Health Market is positioned for robust growth, driven by ongoing investments in healthcare infrastructure and the growing recognition of infection control as a critical component of both human and animal health management. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Infection Control for the Human Animal Health Market Infection Type Insights** The Infection Type segment of the South Korea Infection Control for the Human Animal Health Market is critical as it focuses on distinct categories of infectionsviral, bacterial, parasitic, and fungal. Each of these types presents unique challenges and requires specific management strategies. Viral infections, often characterized by rapid transmission rates among human and animal populations, necessitate ongoing Research and Development efforts to enhance vaccine effectiveness and antiviral therapies. Bacterial infections, frequently linked to zoonotic diseases, are significant due to their potential for causing severe health issues and the increasing prevalence of antibiotic-resistant strains.Parasitic infections, particularly in livestock, impact both animal health and agricultural productivity, underscoring the need for comprehensive control measures. Fungal infections, while sometimes overlooked, pose substantial risks, especially in immunocompromised hosts. As South Korea continues to prioritize public health and food safety, effective management across these infection types will remain central to mitigating risks and enhancing healthcare outcomes, driving substantial growth within the industry. The South Korea Infection Control for the Human Animal Health Market segmentation reflects the demand for targeted solutions addressing these varied infection types. **Infection Control for the Human Animal Health Market End User Insights** The South Korea Infection Control for the Human Animal Health Market is experiencing significant growth, particularly within the End User segment, which includes both Human Healthcare Facilities and Animal Healthcare Facilities. Human Healthcare Facilities play a crucial role in the management of infections, given the rising prevalence of healthcare-associated infections and the increasing emphasis on patient safety. The demand for advanced infection control products and procedures is expected to continue growing, driven by stricter regulations and a heightened awareness of hygiene practices among medical professionals.On the other hand, Animal Healthcare Facilities are becoming increasingly vital, especially with the need for effective disease management in livestock and companion animals, which directly impacts public health. This segment is significant due to the rising concerns about zoonotic diseases and the critical need for infection control measures in veterinary practices. The integration of innovative technologies and practices in these facilities is expected to enhance the effectiveness of infection prevention strategies, making both Human and Animal Healthcare Facilities central to the overall growth and development of the South Korea Infection Control for the Human Animal Health Market. **South Korea Infection Control for the Human Animal Health Market Key Players and Competitive Insights** The South Korea Infection Control for the Human Animal Health Market is characterized by a dynamic landscape where innovation, regulatory standards, and consumer demands converge to shape competitive strategies. The market is primarily driven by the increasing consciousness regarding animal health and hygiene, alongside a growing awareness of zoonotic diseases. As veterinary professionals and livestock producers prioritize the highest standards of infection control, various companies have initiated competitive practices that enhance their market positioning. The focus on research and development, along with technological advancements, has resulted in a landscape where players constantly strive to meet the evolving needs of the market. Understanding the competitive dynamics, including strengths and market strategies of leading firms, is crucial for stakeholders looking to navigate this complex environment effectively.Agrovet Market has established a formidable presence in the South Korean Infection Control for the Human Animal Health Market, bringing forth a robust portfolio of veterinary products that prioritize infection management and health improvement for both companion and livestock animals. The company is known for its innovative solutions that are tailored to meet local regulatory standards and consumer preferences. Agrovet Market's strengths lie in its extensive distribution network, strong relationships with veterinary professionals, and a commitment to quality and efficacy in its offerings. Additionally, the organization has been proactive in addressing market demands, which enhances its competitive edge and solidifies its role as a key player in the region.Bayer Animal Health stands out as a significant contributor to the Infection Control for the Human Animal Health Market in South Korea, with a diverse range of products aimed at enhancing animal health and wellness. The company offers several key products and services that include anti-infectives, vaccines, and parasite control solutions, all tailored to local needs and compliance standards. Bayer's strong market presence is bolstered by its commitment to research and development, which enables the introduction of innovative solutions that address emerging health threats. Strengthened by strategic mergers and acquisitions, Bayer Animal Health has been able to expand its capabilities and reach in South Korea. The company’s integration of cutting-edge technology into its offerings serves as a considerable competitive advantage, driving both effectiveness and affordability in infection control measures for livestock and pets alike. **Key Companies in the South Korea Infection Control for the Human Animal Health Market Include** - Agrovet Market - Bayer Animal Health - Vetoquinol - Phileo Lesaffre Animal Care - Merck Animal Health - Huvepharma - Boehringer Ingelheim - Virbac - Elanco Animal Health - Vetbiobank - Cegelec - NEOGEN Corporation - Zoetis - Petmed Express - Cypress Drug Company **South Korea Infection Control for the Human Animal Health Market Industry Developments** Recent developments in the South Korea Infection Control for the Human Animal Health Market have highlighted significant advancements and regulatory efforts aimed at enhancing the industry. Notably, in September 2023, Bayer Animal Health announced the launch of its new vaccine specifically targeting infectious diseases in livestock, which has ramped up interest in the sector. Meanwhile, Zoetis experienced growth in market valuation as its innovative diagnostic tools gained traction among veterinarians, reflecting a shift towards precision animal health solutions. The ongoing COVID-19 pandemic has further propelled demand for infection control measures, resulting in an uptick in product offerings from companies like Merck Animal Health and Virbac. In terms of mergers and acquisitions, in June 2023, Elanco Animal Health announced its acquisition of a local biotech firm, enhancing its portfolio in animal vaccines, a move well-received within the market. Furthermore, government initiatives promoting animal health product registrations have streamlined processes, benefiting many firms such as Huvepharma and Vetoquinol. In the past three years, there has been a significant increase in investments related to Research and Development in this field, further solidifying South Korea's position as a central player in animal health solutions in the Asia-Pacific region. **South Korea Infection Control for the Human Animal Health Market Segmentation Insights** **Infection Control for the Human Animal Health Market Product****Outlook** - Disinfection Products - Personal Protective Equipment (PPE) - Sterilization Equipment **Infection Control for the Human Animal Health Market Infection Type****Outlook** - Viral - Bacterial - Parasitic - Fungal Infections **Infection Control for the Human Animal Health Market End User****Outlook** - Human Healthcare Facilities - Animal Healthcare Facilities ## Market Drivers ### Increasing Pet Ownership The rising trend of pet ownership in South Korea appears to be a driving force for the Global South Korea Infection Control for the Human [Animal Health](https://www.marketresearchfuture.com/reports/animal-health-market-7163) Market Industry. As more households adopt pets, the demand for [veterinary services](https://www.marketresearchfuture.com/reports/veterinary-service-market-42245) and infection control measures is likely to increase. This trend may lead to a greater emphasis on preventive healthcare and vaccination programs, which are essential for maintaining animal health and preventing zoonotic diseases. Consequently, the market could see substantial growth, reflecting the changing dynamics of pet ownership and its implications for public health. ### Global Trade and Animal Movement The expansion of global trade and the movement of animals across borders seem to pose both opportunities and challenges for the Global South Korea Infection Control for the Human Animal Health Market Industry. Increased international trade can facilitate the spread of diseases, necessitating robust infection control measures to safeguard public health. As countries implement stricter biosecurity protocols, the demand for effective infection control solutions is likely to rise. This dynamic could contribute to the market's growth trajectory, aligning with the projected figures of 1250 USD Million in 2024 and 2750 USD Million by 2035. ### Rising Awareness of Zoonotic Diseases The increasing awareness of zoonotic diseases among the population appears to be a significant driver for the Global South Korea Infection Control for the Human Animal Health Market Industry. As more individuals recognize the potential transmission of diseases from animals to humans, there is a growing demand for effective infection control measures. This heightened awareness is likely to lead to increased investments in veterinary services and public health initiatives, thereby contributing to the market's growth. The market is projected to reach 1250 USD Million in 2024, reflecting the urgency for enhanced infection control protocols. ### Government Initiatives and Regulations Government initiatives aimed at improving public health and animal welfare are likely to play a crucial role in shaping the Global South Korea Infection Control for the Human Animal Health Market Industry. Regulatory frameworks that mandate stringent infection control practices in veterinary clinics and farms could drive market growth. For instance, the South Korean government has implemented various policies to enhance biosecurity measures, which may lead to increased compliance among stakeholders. Such initiatives could potentially contribute to the market's expansion, with projections indicating a growth to 2750 USD Million by 2035. ### Technological Advancements in Diagnostics Technological advancements in diagnostic tools and methodologies are expected to significantly influence the Global South Korea Infection Control for the Human Animal Health Market Industry. Innovations such as rapid testing kits and advanced imaging techniques may enhance the ability to detect infections early, thereby improving treatment outcomes. The integration of artificial intelligence in diagnostics could streamline processes and reduce the time taken to identify pathogens. This technological evolution is likely to attract investments and foster growth, with a projected CAGR of 7.43% from 2025 to 2035, indicating a robust future for the market. ## Future Outlook The South Korea Infection Control for the Human Animal Health Market is projected to grow at a 7.43% CAGR from 2025 to 2035, driven by technological advancements and increasing health awareness. **New opportunities:** - Develop innovative disinfectant formulations targeting emerging pathogens. Leverage digital platforms for real-time infection monitoring solutions. Expand partnerships with veterinary clinics for integrated health management services. By 2035, the market is expected to achieve substantial growth, reflecting enhanced infection control measures and increased investment. ## Segment Insights ### South Korea Infection Control for the Human Animal Health Market Segment Insights South Korea [Infection Control for the Human Animal Health](https://www.marketresearchfuture.com/reports/infection-control-for-the-human-animal-health-market-21608) Market Segment Insights ### Infection Control for the Human Animal Health Market Product Insights Infection Control for the Human Animal Health Market Product Insights The Product segment of the South Korea Infection Control for the Human Animal Health Market plays a critical role in ensuring health safety across populations and industries. This market encompasses various solutions designed to prevent the spread of infections, highlighting the importance of hygiene in both human and animal health contexts. Disinfection Products are essential in mitigating pathogens, with a significant portion of the industry focusing on developing and distributing effective antimicrobial agents for various surfaces and environments, particularly given the high population density and urbanization observed in South Korea. Personal Protective Equipment (PPE) is another vital aspect of this segment, providing necessary safeguards for healthcare workers, veterinarians, and public health officials, especially during outbreaks or situations requiring stringent infection control measures. Furthermore, Sterilization Equipment plays a significant role in clinical settings, ensuring that surgical instruments and other medical devices are free from contamination, thereby enhancing patient safety. The demand for these products is driven by increasing awareness regarding healthcare-associated infections and animal disease outbreaks, along with strengthening regulations and standards governing infection control protocols. ### Infection Control for the Human Animal Health Market Infection Type Insights Infection Control for the Human Animal Health Market Infection Type Insights The Infection Type segment of the South Korea Infection Control for the Human Animal Health Market is critical as it focuses on distinct categories of infectionsviral, bacterial, parasitic, and fungal. Each of these types presents unique challenges and requires specific management strategies. Viral infections, often characterized by rapid transmission rates among human and animal populations, necessitate ongoing Research and Development efforts to enhance vaccine effectiveness and antiviral therapies. Bacterial infections, frequently linked to zoonotic diseases, are significant due to their potential for causing severe health issues and the increasing prevalence of antibiotic-resistant strains.Parasitic infections, particularly in livestock, impact both animal health and agricultural productivity, underscoring the need for comprehensive control measures. Fungal infections, while sometimes overlooked, pose substantial risks, especially in immunocompromised hosts. As South Korea continues to prioritize public health and food safety, effective management across these infection types will remain central to mitigating risks and enhancing healthcare outcomes, driving substantial growth within the industry. ### Infection Control for the Human Animal Health Market End User Insights Infection Control for the Human Animal Health Market End User Insights The South Korea Infection Control for the Human Animal Health Market is experiencing significant growth, particularly within the End User segment, which includes both Human Healthcare Facilities and Animal Healthcare Facilities. Human Healthcare Facilities play a crucial role in the management of infections, given the rising prevalence of healthcare-associated infections and the increasing emphasis on patient safety. The demand for advanced infection control products and procedures is expected to continue growing, driven by stricter regulations and a heightened awareness of hygiene practices among medical professionals.On the other hand, Animal Healthcare Facilities are becoming increasingly vital, especially with the need for effective disease management in livestock and companion animals, which directly impacts public health. This segment is significant due to the rising concerns about zoonotic diseases and the critical need for infection control measures in veterinary practices. ## Competitive Benchmarking The South Korea Infection Control for the Human Animal Health Market is characterized by a dynamic landscape where innovation, regulatory standards, and consumer demands converge to shape competitive strategies. The market is primarily driven by the increasing consciousness regarding animal health and hygiene, alongside a growing awareness of zoonotic diseases. As veterinary professionals and livestock producers prioritize the highest standards of infection control, various companies have initiated competitive practices that enhance their market positioning. The focus on research and development, along with technological advancements, has resulted in a landscape where players constantly strive to meet the evolving needs of the market. Understanding the competitive dynamics, including strengths and market strategies of leading firms, is crucial for stakeholders looking to navigate this complex environment effectively.Agrovet Market has established a formidable presence in the South Korean Infection Control for the Human Animal Health Market, bringing forth a robust portfolio of veterinary products that prioritize infection management and health improvement for both companion and livestock animals. The company is known for its innovative solutions that are tailored to meet local regulatory standards and consumer preferences. Agrovet Market's strengths lie in its extensive distribution network, strong relationships with veterinary professionals, and a commitment to quality and efficacy in its offerings. Additionally, the organization has been proactive in addressing market demands, which enhances its competitive edge and solidifies its role as a key player in the region.Bayer Animal Health stands out as a significant contributor to the Infection Control for the Human Animal Health Market in South Korea, with a diverse range of products aimed at enhancing animal health and wellness. The company offers several key products and services that include anti-infectives, vaccines, and parasite control solutions, all tailored to local needs and compliance standards. Bayer's strong market presence is bolstered by its commitment to research and development, which enables the introduction of innovative solutions that address emerging health threats. Strengthened by strategic mergers and acquisitions, Bayer Animal Health has been able to expand its capabilities and reach in South Korea. The company’s integration of cutting-edge technology into its offerings serves as a considerable competitive advantage, driving both effectiveness and affordability in infection control measures for livestock and pets alike. ## Recent News & Developments Recent developments in the South Korea Infection Control for the Human Animal Health Market have highlighted significant advancements and regulatory efforts aimed at enhancing the industry. Notably, in September 2023, Bayer Animal Health announced the launch of its new vaccine specifically targeting infectious diseases in livestock, which has ramped up interest in the sector. Meanwhile, Zoetis experienced growth in market valuation as its innovative diagnostic tools gained traction among veterinarians, reflecting a shift towards precision animal health solutions. The ongoing COVID-19 pandemic has further propelled demand for infection control measures, resulting in an uptick in product offerings from companies like Merck Animal Health and Virbac. In terms of mergers and acquisitions, in June 2023, Elanco Animal Health announced its acquisition of a local biotech firm, enhancing its portfolio in [animal vaccines](https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184), a move well-received within the market. Furthermore, government initiatives promoting animal health product registrations have streamlined processes, benefiting many firms such as Huvepharma and Vetoquinol. In the past three years, there has been a significant increase in investments related to Research and Development in this field, further solidifying South Korea's position as a central player in animal health solutions in the Asia-Pacific region. ## Report Scope | Report Attribute/Metric Source: | Details | | --- | --- | | MARKET SIZE 2023 | 191.2(USD Million) | | MARKET SIZE 2024 | 206.8(USD Million) | | MARKET SIZE 2035 | 500.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.357% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | MARKET FORECAST PERIOD | 2025 - 2035 | | HISTORICAL DATA | 2019 - 2024 | | MARKET FORECAST UNITS | USD Million | | KEY COMPANIES PROFILED | Agrovet Market, Bayer Animal Health, Vetoquinol, Phileo Lesaffre Animal Care, Merck Animal Health, Huvepharma, Boehringer Ingelheim, Virbac, Elanco Animal Health, Vetbiobank, Cegelec, NEOGEN Corporation, Zoetis, Petmed Express, Cypress Drug Company | | SEGMENTS COVERED | Product, Infection Type, End User | | KEY MARKET OPPORTUNITIES | Innovative disinfection technology, Rapid testing solutions demand, Sustainable infection control products, Integrated health management systems, Increased livestock biosecurity awareness | | KEY MARKET DYNAMICS | Regulatory compliance requirements, Increasing zoonotic disease awareness, Advanced disinfection technologies, Growing veterinary health expenditure, Rise in pet ownership trends | | COUNTRIES COVERED | South Korea | ## Frequently Asked Questions **Q: What is the expected market size of the South Korea Infection Control for the Human Animal Health Market in 2024?** A: The market is expected to be valued at 206.8 million USD in 2024. **Q: What is the projected market size for this market by 2035?** A: By 2035, the market is projected to reach a value of 500.0 million USD. **Q: What is the expected compound annual growth rate (CAGR) for the market from 2025 to 2035?** A: The expected CAGR for the South Korea Infection Control for the Human Animal Health Market is 8.357% during the period from 2025 to 2035. **Q: Which segment of the market is expected to have the highest value in 2024?** A: The Disinfection Products segment is expected to have the highest value at 82.0 million USD in 2024. **Q: What is the expected value of the Personal Protective Equipment (PPE) segment in 2035?** A: The Personal Protective Equipment (PPE) segment is expected to be valued at 140.0 million USD by 2035. **Q: Which key players dominate the South Korea Infection Control for the Human Animal Health Market?** A: Key players in the market include Bayer Animal Health, Merck Animal Health, and Zoetis, among others. **Q: What is the projected market size for Sterilization Equipment in 2035?** A: The Sterilization Equipment segment is projected to reach a value of 165.0 million USD by 2035. **Q: How is the growth rate for the Disinfection Products segment expected to trend from 2025 to 2035?** A: The Disinfection Products segment is expected to grow significantly, reaching 195.0 million USD in 2035. **Q: What challenges might the South Korea Infection Control market face in the coming years?** A: Challenges may include regulatory compliance and competition among key players in the market. **Q: Can you identify a key growth driver for the South Korea Infection Control for the Human Animal Health Market?** A: Increasing focus on animal health and biosecurity measures is a significant growth driver for the market. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-infection-control-human-and-animal-health-market-53389*